FDA Authorizes New Test To Detect Past Covid-19 Infections

Home » Where To Get T-detect Test » FDA Authorizes New Test To Detect Past Covid-19 Infections

Maybe your like

Skip to Main Content STAT+

The Food and Drug Administration on Friday issued an emergency authorization for a new test to detect Covid-19 infections — one that stands apart from the hundreds already authorized.

Unlike tests that detect bits of SARS-CoV-2 or antibodies to it, the new test, called T-Detect COVID, looks for signals of past infections in the body’s adaptive immune system — in particular, the T cells that help the body remember what its viral enemies look like. Developed by Seattle-based Adaptive Biotechnologies, it is the first test of its kind.

Advertisement

Adaptive’s approach involves mapping antigens to their matching receptors on the surface of T cells. They and other researchers had already shown that the cast of T cells floating around in an individual’s blood reflects the diseases they’ve encountered, in many cases years later. The next step is trying to unlock that information to help diagnose those past infections.

STAT+ Exclusive Story

Already have an account? Log in

STAT+ STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans STAT+

To read the rest of this story subscribe to STAT+.

Subscribe Log In

About the Author Reprints

Katie Palmer

Katie Palmer

Health Tech Correspondent

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can reach Katie on Signal at palmer.01.

[email protected] @KatieMPalmer

Tags

Artificial intelligence

Coronavirus

To submit a correction request, please visit our Contact Us page.

NIH redefines ‘clinical trials,’ dividing researchers  NIH redefines ‘clinical trials,’ dividing researchers  Benzodiazepines: our other prescription drug epidemic Benzodiazepines: our other prescription drug epidemic Trump administration is urged to use a federal law… Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs FDA’s rejection of Moderna threatens to stifle broader vaccine… FDA’s rejection of Moderna threatens to stifle broader vaccine industry Researchers take another look at Apple’s hypertension feature Researchers take another look at Apple’s hypertension feature Big Health raises funding as investors see glimmer of… Big Health raises funding as investors see glimmer of hope for digital therapeutics

Recommended Stories

Exclusive Lizzy Lawrence

STAT Plus: Prasad overruled FDA staff to reject Moderna’s flu vaccine application

Biotech Matthew Herper and Helen Branswell

STAT Plus: FDA refuses to review Moderna’s influenza vaccine

Advertisement

Exclusive Allison DeAngelis

STAT Plus: Biotech doubles financing in quest to silence genes behind neurological diseases

A STAT Examination John Wilkerson, J. Emory Parker, Chelsea Cirruzzo, Elaine Chen, and Daniel Payne

TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics

Biotech Allison DeAngelis

STAT Plus: A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all

Tag » Where To Get T-detect Test